Effects of a Hybrid Education Programme for Korean Mothers of Children with Atopic Dermatitis

Yoo, Juhyun; Gagné, Jennie C. De; Jeong, Seung-Hyeon S; Jeong, Chan Woo

doi:10.2340/00015555-2862

Cited by 7 publications

(23 citation statements)

References 33 publications

(38 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…316,317 Internet-delivered (eHealth) self-management was investigated in recent years mostly with cognitive behavioural interventions. 306,318 Results demonstrate similar effects such as face-to-face psychotherapy. 319 Studies involving dermatologic patients are promising.…”

Section: Psychosomatic Aspects and Therapeutic Patient Educationmentioning

confidence: 77%

“…Adjuvant psychosocial programmes focused on itch are most effective in AD, and many randomized controlled trials have been published in the recent years. [295][296][297][298][299][300][301][302][303][304][305][306] Such programmes include strategies for breaking the vicious circle of itching and scratching, relaxation and stress management techniques as well as strategies for dealing with relapses. More than 10 randomized controlled studies 296,307,308 and a Cochrane review about psychological interventions showed slightly beneficial effects.…”

Section: Psychosomatic Aspects and Therapeutic Patient Educationmentioning

confidence: 99%

“…Most publications on psychotherapeutic and psychopharmacologic interventions, however, refer to small groups or single case reports 316,317 . Internet‐delivered (eHealth) self‐management was investigated in recent years mostly with cognitive behavioural interventions 306,318 . Results demonstrate similar effects such as face‐to‐face psychotherapy 319 .…”

Section: Psychosomatic Aspects and Therapeutic Patient Educationmentioning

confidence: 99%

See 2 more Smart Citations

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

Wollenberg

Christen-Zäch

Taı̈eb

et al. 2020

Acad Dermatol Venereol

301

360

View full text Add to dashboard Cite

Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease. The diagnosis is made using evaluated clinical criteria. Disease activity and burden are best measured with a composite score, assessing both objective and subjective symptoms, such as SCORing Atopic Dermatitis (SCORAD). AD management must take into account clinical and pathogenic variabilities, the patient's age and also target flare prevention. Basic therapy includes hydrating and barrierstabilizing topical treatment universally applied, as well as avoiding specific and unspecific provocation factors. Visible skin lesions are treated with anti-inflammatory topical agents such as corticosteroids and calcineurin inhibitors (tacrolimus and pimecrolimus), which are preferred in sensitive locations. Topical tacrolimus and some mid-potency corticosteroids are proven agents for proactive therapy, which is defined as the long-term intermittent anti-inflammatory therapy of frequently relapsing skin areas. Systemic anti-inflammatory or immunosuppressive treatment is a rapidly changing † See Appendix section.

show abstract

Section: Psychosomatic Aspects and Therapeutic Patient Educationmentioning

confidence: 77%

Section: Psychosomatic Aspects and Therapeutic Patient Educationmentioning

confidence: 99%

Section: Psychosomatic Aspects and Therapeutic Patient Educationmentioning

confidence: 99%

See 1 more Smart Citation

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

Wollenberg

Christen-Zäch

Taı̈eb

et al. 2020

Acad Dermatol Venereol

301

360

View full text Add to dashboard Cite

show abstract

“…There is good evidence of the benefit from patient education programs mainly delivered by Internet‐based programs. Physicians should explore the disposition of parents, respectively, adult patients toward such programs and, if possible, recommend their use (Liang et al, ; Siebert, Qureshi, Chu, & Goff, ; Yoo, De Gagne, Jeong, & Jeong, ).…”

Section: General Measures and Avoidance Strategiesmentioning

confidence: 99%

“…Physicians should explore a possible presence of corticophobia and in relevant cases seek psychological counseling for the patients (respectively, the parents; A, 1a).There is good evidence of the benefit from patient education programs mainly delivered by Internet-based programs. Physicians should explore the disposition of parents, respectively, adult patients toward such programs and, if possible, recommend their use(Liang et al, 2018;Siebert, Qureshi, Chu, & Goff, 2019;Yoo, De Gagne, Jeong, & Jeong, 2018).…”

mentioning

confidence: 99%

Italian guidelines for therapy of atopic dermatitis—Adapted from consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis)

Damiani

Calzavara‐Pinton

Stingeni

et al. 2019

Dermatologic Therapy

View full text Add to dashboard Cite

Atopic dermatitis (AD) therapeutic approach calls for a long‐term treatment. Treatment options for AD have recently undergone a revolutionary change by the introduction of the first biologic drug. Availability in daily practice of the last version of international AD guidelines, taking peculiarities of the country into account, can contribute to good clinical practice in Italy. To adapt European Dermatology Forum (EDF) guidelines for AD to the Italian medical–legal context, the EDF guidelines were assessed independently by two independent Italian renowned experts in the field and further integrated with articles published and systematically reviewed before May 2019. The first draft was collegially corrected and updated by the members of the SIDEMAST, ADOI, and SIDAPA. Recommendation levels (A; B; C; D) were graded based on the evidence levels (1–4). The adapted guidelines presented here focus on topical and systemic therapies in AD patients, both children and adults. As opposed to previous Italian guidelines, they include indications about biologics. New relevant evidence available from very recent literature and peculiarities of the Italian medical and legal context have been integrated in the revision process. If compared to general guidelines for AD not adapted to a specific national and cultural context, a revision for specific Italian needs is now available: It comprises the option of implementing the new biologic treatments and is likely to provide an important contribution to the improvement of clinical practice in Italy. Cooperation between patients, dermatologists, allergologists, and pediatricians remains mandatory in AD management. The authors of the present revision recommend an update of the Italian guidelines to be performed at least every second year.

show abstract

Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review

Carrera¹,

Hammadi

Huang

et al. 2019

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

Atopic dermatitis (AD), the leading cause of skin-related burden of disease worldwide, is increasing in prevalence in developing countries of Asia, Africa, Latin America, and the Middle East. Although AD presents similarly across racial and ethnic groups as chronic and relapsing pruritic eczematous lesions, some features of the disease may be more or less prominent in patients with darker skin. Despite a similar presentation, consistent diagnostic criteria and consistent treatment guidelines are lacking. Because of these and other challenges, adherence to treatment guidelines is difficult or impossible. Previous studies have stated that many patients with AD receive ineffective or inappropriate care, such as oral antihistamines, oral corticosteroids, or traditional medicines, if they are treated at all; one study showed that approximately one-third of patients received medical care for their dermatologic condition; of those, almost three-quarters received inappropriate or ineffective treatment. In addition, other challenges endemic to developing countries include cost, access to care, and lack of specialists in AD. Furthermore, most of the available diagnostic criteria and treatment guidelines are based on European and North American populations and few clinical trials report the racial or ethnic makeup of the study population. Drug pharmacokinetics in varying ethnicities and adverse effects in different skin physiologies are areas yet to be explored. The objective of this review is to describe the diagnosis, treatment, and management of AD in developing countries in Asia, Africa, Latin America, and the Middle East; to discuss the differences among the countries; and to establish the unmet needs of patients with AD in them. The unmet medical need for treatment of AD in developing countries can be addressed by continuing to train medical specialists, improve Enhanced Digital Features To view enhanced digital features for this article go to https://doi.org/10.6084/ m9.figshare.9918782.

show abstract

Effects of a Hybrid Education Programme for Korean Mothers of Children with Atopic Dermatitis

Cited by 7 publications

References 33 publications

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

Italian guidelines for therapy of atopic dermatitis—Adapted from consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis)

Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review

Contact Info

Product

Resources

About